Form 8-K - Current report:
SEC Accession No. 0001596783-23-000171
Filing Date
2023-11-15
Accepted
2023-11-15 07:05:25
Documents
14
Period of Report
2023-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ctlt-20231115.htm   iXBRL 8-K 30082
2 EX-99.1 earningsreleaseex991-fy24x.htm EX-99.1 439949
6 image1.jpg GRAPHIC 45267
  Complete submission text file 0001596783-23-000171.txt   688772

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctlt-20231115.xsd EX-101.SCH 2209
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctlt-20231115_lab.xml EX-101.LAB 24695
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctlt-20231115_pre.xml EX-101.PRE 13095
8 EXTRACTED XBRL INSTANCE DOCUMENT ctlt-20231115_htm.xml XML 2707
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

EIN.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36587 | Film No.: 231409017
SIC: 2834 Pharmaceutical Preparations